Serial 98609776
Live / Applied — Second extension granted (statement of use) (as of 03 Mar 2026)
What this means for you
Not registered yet, but its 20 Jun 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98609776
- Mark type
- Design / logo
- Filed
- 20 Jun 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Scott D. Woldow
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Pharmaceutical preparations for the treatment of autoimmune diseases, illnesses and conditions; Pharmaceutical preparations, namely, immunosuppressants; Pharmaceutical preparations for the treatment of plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, polyarticular juvenile idiopathic arthritis and active enthesitis related arthritis, Crohn's disease, ulcerative colitis, hidradenitis colitis, hidradenitis suppurativa and non-infectious uveitis; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Biologics, namely, biological preparations for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections; Biologics, namely, biological preparations for the treatment of ankylosing spondylitis; Biological preparations for the treatment of and reducing signs and symptoms in adult patients with active ankylosing spondylitis; Protein therapeutics, namely, protein supplements; Pharmaceutical preparations for treating ankylosing spondylitis; Pharmaceutical preparations for the treatment of and for reducing signs and symptoms in adult patients with active ankylosing spondylitis
Owner
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
- Fresenius Kabi Deutschland GmbH, Bad Homburg, DE
Prosecution history
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Mar 2026 — SOU EXTENSION 2 GRANTED
- 03 Mar 2026 — SOU EXTENSION 2 FILED
- 03 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 24 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 1 GRANTED
- 24 Sept 2025 — SOU EXTENSION 1 FILED
- 24 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jan 2025 — ASSIGNED TO EXAMINER
- 12 Jan 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED